1. Exercise training reduces sympathetic nerve activity and improves executive performance in individuals with obstructive sleep apnea
- Author
-
Thiago Tanaka Goya, Rosyvaldo Ferreira-Silva, Elisangela Macedo Gara, Renan Segalla Guerra, Eline Rozária Ferreira Barbosa, Edgar Toschi-Dias, Paulo Jannuzzi Cunha, Carlos Eduardo Negrão, Geraldo Lorenzi-Filho, and Linda Massako Ueno-Pardi
- Subjects
Exercise Training ,Sympathetic Nervous System ,Executive Function ,Obstructive Sleep Apnea ,Medicine (General) ,R5-920 - Abstract
OBJECTIVE: To investigate the effects of exercise training (ET) on muscle sympathetic nerve activity (MSNA) and executive performance during Stroop Color Word Test (SCWT) also referred to as mental stress test. METHODS: Forty-four individuals with obstructive sleep apnea (OSA) and no significant co-morbidities were randomized into 2 groups; 15 individuals completed the control period, and 18 individuals completed the ET. Mini-mental state of examination and intelligence quotient were also assessed. MSNA assessed by microneurography, heart rate by electrocardiography, blood pressure (automated oscillometric device) were measured at baseline and during 3 min of the SCWT. Peak oxygen uptake (VO2 peak) was evaluated using cardiopulmonary exercise testing. Executive performance was assessed by the total correct responses during 3 min of the SCWT. ET consisted of 3 weekly sessions of aerobic exercise, resistance exercises, and flexibility (72 sessions, achieved in 40±3.9 weeks). RESULTS: Baseline parameters were similar between groups. Heart rate, blood pressure, and MSNA responses during SCWT were similar between groups (p>0.05). The comparisons between groups showed that the changes in VO2 (4.7±0.8 vs -1.2±0.4) and apnea-hypopnea index (-7.4±3.1 vs 5.5±3.3) in the exercise-trained group were significantly greater than those observed in the control group respectively (p0.05). CONCLUSIONS: ET improves sympathetic response and executive performance during SCWT, suggesting a prominent positive impact of ET on prefrontal functioning in individuals with OSA. ClinicalTrials.gov: NCT002289625.
- Published
- 2021
- Full Text
- View/download PDF